Why BioNTech Stock Is Soaring Today
_0.png?locale=us){kind=logo}
Shares of BioNTech (NASDAQ: BNTX) were soaring 17.7% as of 10:57 a.m. EDT on Monday. The big gain came after BioNTech and its partner, Pfizer (NYSE: PFE), announced that two vaccine candidates being developed for SARS-CoV-2, the coronavirus that causes COVID-19, received Fast Track designation from the U.S. Food and Drug Administration (FDA).
It makes sense that the biotech stock jumped today; receiving Fast Track designation is definitely good news for BioNTech and for Pfizer. The FDA's decision means that the companies' two COVID-19 vaccine candidates, BNT162b1 and BNT162b2, will enjoy an expedited FDA review process. BioNTech and Pfizer will also be able to work more closely with the FDA on clinical trial plans.
Image source: Getty Images.
Source Fool.com
